High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis – a randomized controlled trial

High dose vitamin D supplementation does not affect biochemical bone markers in multiple sclerosis – a randomized controlled trial

Abstract Background People with multiple sclerosis have high risk of osteoporosis and fractures. A poor vitamin D status is a risk factor for MS, and vitamin D supplementation has been recommended both to prevent MS progression and to maintain bone health. Methods We assessed the effect of 20,000 IU...

Full description

Bibliographic Details
Main Authors: Trygve Holmøy, Jonas Christoffer Lindstrøm, Erik Fink Eriksen, Linn Hofsøy Steffensen, Margitta T. Kampman
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
vitamin D
osteoporosis
randomized controlled trial
Online Access:http://link.springer.com/article/10.1186/s12883-017-0851-0

Internet

http://link.springer.com/article/10.1186/s12883-017-0851-0

Similar Items